[1]蒋 雨,冯 吉,朱和林,等.胃部手术后加速康复与传统康复随机对照的荟萃分析[J].医学信息,2023,36(22):1-7.[doi:10.3969/j.issn.1006-1959.2023.22.001]
　JIANG Yu,FENG Ji,ZHU He-lin,et al.A Meta-analysis of Randomized Controlled Trials of Accelerated Rehabilitation and Traditional Rehabilitation After Gastric Surgery[J].Journal of Medical Information,2023,36(22):1-7.[doi:10.3969/j.issn.1006-1959.2023.22.001]
点击复制

胃部手术后加速康复与传统康复随机对照的荟萃分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年22期
页码:
1-7
栏目:
医学数据科学
出版日期:
2023-11-15

文章信息/Info

Title:
A Meta-analysis of Randomized Controlled Trials of Accelerated Rehabilitation and Traditional Rehabilitation After Gastric Surgery
文章编号:
1006-1959（2023）22-0001-07
作者:
蒋 雨; 冯 吉; 朱和林; 等
（1.西安医学院临床医学院，陕西 西安 710021；2.西安市常见老龄疾病防治重点实验室/慢病防治研究与转化中心/基础与转化医学研究所/西安医学院，陕西 西安 710021）
Author(s):
JIANG Yu; FENG Ji; ZHU He-lin; et al.
(1.School of Clinical Medicine,Xi’an Medical University,Xi’an 710021,Shaanxi,China; 2.Xi’an Key Laboratory for Prevention and Treatment of Common Aging Diseases/Translation and Research Centre for Prevention and Therapy of Chronic Disease/Institute of Basic and Translation Medicine/Xi’an Medical University,Xi’an 710021,Shaanxi,China)
关键词:
加速康复外科; 胃癌; 胃切除术; 减重手术; 随机对照试验
Keywords:
Enhanced recovery after surgery gastric cancer; Gastrectomy; Bariatric surgery; Randomized controlled trials
分类号:
R735.2
DOI:
10.3969/j.issn.1006-1959.2023.22.001
文献标志码:
A
摘要:
目的 探讨加速康复外科（ERAS）在胃外科手术中的安全性和有效性。方法 检索PubMed、Web of Knowledge、EMbase和Cochrane图书馆建库至2022年3月14日关于胃部手术（胃癌和减重手术）的术后患者接受ERAS方案和传统护理康复的随机对照试验（RCTs）。运用Review Manager 5.4软件和Stata 12.0软件进行统计分析。结果 最终共纳入13项RCTs。Meta分析显示，ERAS组术后并发症发生率、术后24 h的VAS评分、住院花费低于CC组，术中出血量少于CC组，总住院时间、术后住院时间、首次排气时间、首次排便时间、首次流质饮食时间、首次下床活动时间均短于CC组，差异有统计学意义（P＜0.05）。ERAS组和CC组Clavien-Dindo Ⅲa级以上并发症发生率、手术时间、再手术发生率、再住院发生率和术后死亡率比较，差异无统计学意义（P＞0.05）。结论 在胃外科手术中，ERAS方案可在一定程度上有利于减少术后并发症，加速术后恢复，节省医疗费用，且不增加患者再手术、再入院等术后短期死亡率等额外负担的风险。
Abstract:
Objective To investigate the safety and efficacy of enhanced recovery after surgery (ERAS) in gastric surgery.Methods Randomized controlled trials (RCTs) involving ERAS protocols for gastric surgery(gastric cancer and bariatric surgery) and conventional care recovery in PubMed, Web of Knowledge, EMbase and Cochrane library from database inception to March 14, 2022 were searched. All data in this study were statistically analyzed using Review Manager 5.4 software and Stata 12.0 software.Results Finally, a total of 13 RCTs were included. Meta-analysis showed that the incidence of postoperative complications, VAS score at 24 h after operation and hospitalization cost in the ERAS group were lower than those in the CC group, and the intraoperative blood loss was less than that in the CC group, the total hospitalization time, postoperative hospitalization time, first exhaust time, first defecation time, first liquid diet time and first ambulation time in the ERAS group were shorter than those in the CC group, with statistically significant differences (P<0.05). There was no significant difference in the incidence of complications above Clavien-Dindo Ⅲa, operation time, reoperation rate, rehospitalization rate and postoperative mortality between the ERAS group and the CC group (P>0.05).Conclusion In gastric surgery, the ERAS program is beneficial to reduce postoperative complications, accelerate postoperative recovery, save medical costs, and does not increase the risk of additional short-term mortality such as re-operation and re-admission.

参考文献/References:

[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.[2]de Martel C,Georges D,Bray F,et al.Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis[J].Lancet Glob Health,2020,8(2):e180-e190.[3]Song ZY,Wu YY,Yang JB,et al.Progress in the treatment of advanced gastric cancer[J].Tumour Biol,2017,39(7):1010428317714626.[4]Obesity:preventing and managing the global epidemic.Report of a WHO consultation[J].World Health Organ Tech Rep Ser,2000,894:i-xii,1-253.[5]Burguera B,Jesús Tur J,Escudero AJ,et al.An Intensive Lifestyle Intervention is an Effective Treatment of Morbid Obesity:The TRAMOMTANA Study-A Two-Year Randomized Controlled Clinical Trial[J].Int J Endocrinol,2015,2015:194696.[6]Adamina M,Kehlet H,Tomlinson GA,et al.Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery[J].Surgery,2011,149(6):830-840.[7]Mortensen K,Nilsson M,Slim K,et al.Enhanced Recovery After Surgery (ERAS○R) Group.Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS○R) Society recommendations[J].Br J Surg,2014,101(10):1209-1229.[8]Moher D,Shamseer L,Clarke M,et al.PRISMA-P Group.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement[J].Syst Rev,2015,4(1):1.[9]Higgins JP,Altman DG,G?覬tzsche PC,et al.Cochrane Bias Methods Group; Cochrane Statistical Methods Group.The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials[J].BMJ,2011,343:d5928.[10]Balshem H,Helfand M,Schünemann HJ,et al.GRADE guidelines: 3.Rating the quality of evidence[J].J Clin Epidemiol,2011,64(4):401-406.[11]Guyatt GH,Oxman AD,Vist GE,et al.GRADE Working Group.GRADE:an emerging consensus on rating quality of evidence and strength of recommendations[J].BMJ,2008,336:924-926.[12]Luo D,Wan X,Liu J,et al.Optimally estimating the sample mean from the sample size,median,mid-range,and/or mid-quartile range[J].Stat Methods Med Res,2018,27(6):1785-1805.[13]Wan X,Wang W,Liu J,et al.Estimating the sample mean and standard deviation from the sample size,median,range and/or interquartile range[J].BMC Med Res Methodol,2014,14:135.[14]Higgins JPT,Green S.Cochrane handbook for systematic reviews of interventions version5.1.0[S].The Cochrane Collaboration,2011.[15]Thorlund K,Devereaux PJ,Wetterslev J,et al.Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?[J].Int J Epidemiol,2009,38(1):276-286.[16]Kang SH,Lee Y,Min SH,et al.Multimodal Enhanced Recovery After Surgery (ERAS) Program is the Optimal Perioperative Care in Patients Undergoing Totally Laparoscopic Distal Gastrectomy for Gastric Cancer: A Prospective,Randomized,Clinical Trial[J].Ann Surg Oncol,2018,25(11):3231-3238.[17]Ruiz-Tovar J,Garcia A,Ferrigni C,et al.Impact of implementation of an enhanced recovery after surgery (ERAS) program in laparoscopic Roux-en-Y gastric bypass: a prospective randomized clinical trial[J].Surg Obes Relat Dis,2019,15(2):228-235.[18]Prabhakaran S,Misra S,Magila M,et al.Randomized Controlled Trial Comparing the Outcomes of Enhanced Recovery After Surgery and Standard Recovery Pathways in Laparoscopic Sleeve Gastrectomy[J].Obes Surg,2020,30(9):3273-3279.[19]Tian YL,Cao SG,Liu XD,et al.Randomized Controlled Trial Comparing the Short-term Outcomes of Enhanced Recovery After Surgery and Conventional Care in Laparoscopic Distal Gastrectomy (GISSG1901)[J].Ann Surg,2022,275(1):e15-e21.[20]Geubbels N,Evren I,Acherman YIZ,et al.Randomized clinical trial of an enhanced recovery after surgery programme versus conventional care in laparoscopic Roux-en-Y gastric bypass surgery[J].BJS Open,2019,3(3):274-281.[21]Cao S,Zheng TH,Wang H,et al.Enhanced Recovery after Surgery in Elderly Gastric Cancer Patients Undergoing Laparoscopic Total Gastrectomy[J].J Surg Res,2021,257:579-586.[22]Li YP,Qiu JF,Cao H.Application of enhanced recovery after surgery for patients with laparoscopic radical gastrectomy[J].J Gastrointest Surg,2016,19(3):269-273.[23]Abdikarim I,Cao XY,Li SZ,et al.Enhanced recovery after surgery with laparoscopic radical gastrectomy for stomach carcinomas[J].World J Gastroenterol,2015,21(47):13339-13344.[24]Tian Y,Li Q,Pan Y.Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer[J].Cancer Biol Med,2021,19(8):1274-1281.[25]Xia MJ,Zhang LY,Tang Z,et al.Laparoscopic Radical Gastrectomy for Resectable Advanced Gastric Cancer Within Enhanced Recovery Programs: A Prospective Randomized Controlled Trial[J].J Laparoendosc Adv Surg Tech A,2017,27(9):959-964.[26]Tanaka R,Lee SW,Kawai M,et al.Protocol for enhanced recovery after surgery improves short-term outcomes for patients with gastric cancer: a randomized clinical trial[J].Gastric Cancer,2017,20(5):861-871.[27]Swaminathan N,Kundra P,Ravi R,et al.ERAS protocol with respiratory prehabilitation versus conventional perioperative protocol in elective gastrectomy- a randomized controlled trial[J].Int J Surg,2020,81:149-157.[28]Wang YY,Zhou Q.The effect of accelerated rehabilitation nursing on postoperative recovery,nutritional status,and psychological status in patients with gastric cancer[J].Am J Transl Res,2021,13(4):3666-3673.[29]Segelman J,Nygren J.Best practice in major elective rectal/pelvic surgery: enhanced recovery after surgery (ERAS)[J].Updat Surg,2017,69:435-439.[30]Li ZY,Wang Q,Li B,et al.Influence of enhanced recovery after surgery programs on laparoscopy-assisted gastrectomy for gastric cancer: a systematic review and meta-analysis of randomized control trials[J].World J Surg Oncol,2017,15(1):207.[31]Dindo D,Demartines N,Clavien PA.Classification of surgical complications a new proposal with evaluation in a cohort of 6 336 patients and results of a survey[J].Ann Surg,2004,240(2):205-213.

相似文献/References:

[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
　YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Journal of Medical Information,2018,31(22):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
　RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Journal of Medical Information,2018,31(22):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
　DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Journal of Medical Information,2018,31(22):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
　PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Journal of Medical Information,2018,31(22):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
　LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(22):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[6]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
　LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Journal of Medical Information,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[7]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
　MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Journal of Medical Information,2018,31(22):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[8]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
　ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Journal of Medical Information,2018,31(22):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[9]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
　WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Journal of Medical Information,2018,31(22):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[10]牛 悦,白建平,卢建跃.HER-2阳性胃癌的研究进展[J].医学信息,2019,32(01):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
　NIU Yue,BAI Jian-ping,LU Jian-yue.Progress in Research of HER-2 Positive Gastric Cancer[J].Journal of Medical Information,2019,32(22):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]

更新日期/Last Update: 1900-01-01